Skip to main content
. 2019 Jan 10;8(1):70. doi: 10.3390/jcm8010070

Table 7.

Disease severity with regard to the CTLA-4 haplotype H1: TAA.

Variable All (n = 644) H1: TAA p-Value
Positive (n = 447) Negative (n = 197)
SOFA 7.0 ± 3.5 7.0 ± 3.6 7.1 ± 3.5 0.5088
SOFA-Respiratory score 2.0 ± 0.8 2.0 ± 0.8 1.9 ± 0.8 0.9796
SOFA-Cardiovascular score 1.5 ± 1.0 1.5 ± 1.0 1.5 ± 1.0 0.7476
SOFA-Central Nervous System score 2.0 ± 1.1 2.0 ± 1.1 1.9 ± 1.1 0.2731
SOFA-Renal score 0.8 ± 1.2 0.7 ± 1.1 0.9 ± 1.3 0.1230
SOFA-Coagulation score 0.4 ± 0.6 0.4 ± 0.6 0.3 ± 0.6 0.6741
SOFA-Hepatic score 0.4 ± 0.7 0.4 ± 0.7 0.4 ± 0.8 0.4264
Organ support
Ventilation days/observation days (%) 66 ± 32 67 ± 32 65 ± 32 0.3607
Vasopressor days/observation days (%) 34 ± 30 33 ± 30 35 ± 30 0.6474
Dialysis days/observation days (%) 9 ± 23 9 ± 22 11 ± 23 0.1246
Inflammatory values
Leucocytes (1000/µL) 13 ± 5 13 ± 5 13 ± 4 0.4087
CRP (mg/L) 152 ± 87 147 ± 81 162 ± 99 0.4562
Procalcitonin (ng/dL) 4.0 ± 9.3 3.5 ± 9.1 5.1 ± 9.7 0.0002
Kidney values
Urine output (mL/day) 2978 ± 1337 3060 ± 1370 2792 ± 1242 0.0229
Urine output (mL/kg/day) 1.6 ± 0.8 1.6 ± 0.8 1.5 ± 0.8 0.0529
Creatinine (mg/dL) 1.2 ± 0.9 1.2 ± 0.9 1.4 ± 1.1 0.0902
Liver values
AST (GOT) (IU/L) 169 ± 598 184 ± 687 131 ± 272 0.9910
ALT (GPT) (IU/L) 94 ± 188 99 ± 206 81 ± 142 0.1307
Bilirubin (mg/dL) 1.2 ± 2.1 1.2 ± 1.8 1.3 ± 2.5 0.9584